Home » News » National Institutes of Health Initiates Multimillion-Dollar Initiative to Prevent Stillbirths and Improve Neonatal Outcomes

National Institutes of Health Initiates Multimillion-Dollar Initiative to Prevent Stillbirths and Improve Neonatal Outcomes

by James Carter Senior News Editor

“`html

Health is investing $37 million in a new consortium dedicated to stillbirth prevention, aiming to address the unacceptably high rate of these tragic losses.">

NIH Launches $37 Million Initiative to Combat Stillbirth Crisis


The National Institutes of Health (NIH) has announced a critically important $37 million, five-year consortium to reduce the rate of stillbirths across the United States, a move applauded by researchers and families impacted by these losses. This initiative addresses a long-standing public health concern, wiht the NIH acknowledging the current rate as ‘unacceptably high.’

The proclamation, made last week, signals a major commitment from the agency to prioritize research and prevention efforts related to stillbirth, defined as the death of a fetus at or after 20 weeks of gestation.

Alison Cernich,Acting Director of the NIH’s Eunice Kennedy Shriver National institute of Child Health and Human Development,emphasized the importance of community involvement. “What we’re really excited about is not onyl the investment in trying to prevent stillbirth, but also continuing that work with the community to guide the research,” she stated.

A Multi-State Collaborative Approach

The consortium will bring together four clinical sites and one data coordinating center located in California, Oregon, Utah, New York, and North carolina. Each site will leverage its unique expertise to tackle different aspects of stillbirth prevention, with a shared focus on prediction, intervention, and support for bereaved families. Research indicates that up to 25% of stillbirths may be preventable, with that figure rising to nearly 50% for deliveries at or beyond 37 weeks of gestation, according to data published in PLoS Medicine.

State Lead Institution Focus Area
California University of California San Diego Placental Function & Fetal Growth
Oregon Oregon Health & Science University Stress, Nutrition, & Heart Health
utah university of Utah Health Thorough Stillbirth Prevention
New York Columbia University Biomarker Identification & Risk Assessment
North Carolina Data Coordinating Center Data Standardization & Analysis

The inaugural meeting of the consortium is scheduled for Friday, where research priorities will be discussed. Proposed areas of investigation include the underlying causes of placental failure, identifying markers of decreased fetal movement, optimizing delivery timing, and utilizing advanced technologies, such as blood tests, biomarkers, and ultrasound, for earlier and more accurate risk prediction. Furthermore, the potential of electronic health records and artificial intelligence in identifying at-risk pregnancies will be explored. Consortium representatives stated they intend to analyze the impact of racial disparities in stillbirth rates as part of their research.

Addressing the Aftermath & Data Gaps

Many families affected by stillbirth struggle with a lack of clear answers regarding the cause of their loss. The consortium will actively collaborate with stillbirth support groups and advisory panels to ensure that research is informed by the lived experiences of those affected. The North carolina team will specifically focus on improving data collection and standardization, addressing a critical need highlighted by previous reports documenting inconsistent and incomplete stillbirth data.

“If we could see the signs and deliver the baby earlier, so that the mom has a live baby, that’s I think what we’re all hoping for,” explained Dr.Cynthia Gyamfi-Bannerman, Chair and Professor of Obstetrics, Gynecology, and Reproductive Sciences at UC San Diego.

A Shift in National Awareness

This new consortium represents a pivotal moment in the national conversation surrounding stillbirth, a previously overlooked public health issue. Recent reporting has brought increased attention to the issue, including a documentary released in 2025 following the journeys of women impacted by stillbirths and their advocacy for safer pregnancies.

Debbie Haine vijayvergiya, featured in the aforementioned documentary, has long campaigned for congressional support for stillbirth legislation and the passage of the Stillbirth Health Improvement and Education (SHINE) for Autumn Act, named in honor of her daughter. Coincidentally, just days after the NIH announced the consortium, bipartisan legislation to reintroduce the SHINE Act was presented in Congress.

“I feel like our moment has finally arrived, and we are being included in all this tremendously vital lifesaving work that’s being done,” Vijayvergiya shared.

The initiative builds upon the work of a previous NIH working group, established by Congress in 2022, which heard directly from families affected by stillbirth and issued a report calling the country’s stillbirth rate “unacceptably high.” The United States currently lags behind other high-income nations in reducing stillbirth rates.

Expert Insights & Future Directions

Dr. Bob Silver, a leading stillbirth expert at the University of Utah Health, with decades of experience in prevention, will co-lead efforts in Utah. “There’s no question that the ProPublica reporting was intimately tied to this,” Silver noted.

Dr.Karen Gibbins, Assistant Professor of Obstetrics and Gynecology at Oregon Health & Science University, expressed her optimism, stating, “Stillbirth is such a huge public health issue, and one that historically has not had as much attention. The fact that we have this investment of centers that are going to be taking these different approaches to fight stillbirth and to prevent stillbirth,and also to provide better care to families who do experience stillbirth,it’s a piece of hope that I think we all needed.”

Frequently Asked Questions About Stillbirth

What is stillbirth?
Stillbirth refers to the loss of a baby at or after 20 weeks of pregnancy.
what causes stillbirth?
The causes of stillbirth are complex and can vary, but may include placental problems, fetal growth restriction, and maternal health conditions.
Is stillbirth preventable?
Research suggests that up to 25% (and perhaps more in later gestation) of stillbirths might potentially be preventable through improved monitoring and intervention.
What is the NIH consortium hoping to achieve?
The consortium aims to identify risk factors, develop predictive tools, and improve care for families experiencing stillbirth.
How can families affected by stillbirth find support?
Numerous support groups and organizations offer resources and guidance for bereaved parents.

Understanding Stillbirth: A Lasting Impact

Did You Know? Approximately 24,000 stillbirths occur in the United States each year, representing a significant public health challenge.

Stillbirth is frequently enough a hidden grief, and open discussion is crucial for destigmatization and improved support for affected families.

Pro Tip: If you are pregnant and experience a significant decrease in fetal movement, contact your healthcare provider immediately.

What are your thoughts on this

What specific biomarkers are being targeted for discovery to predict risk of stillbirth and neonatal complications?

National institutes of Health Initiates Multimillion-Dollar Initiative to Prevent Stillbirths and Improve Neonatal Outcomes

Understanding the Scope of the initiative

The National Institutes of Health (NIH) has launched a significant, multimillion-dollar research initiative focused on dramatically reducing the incidence of stillbirth and improving outcomes for newborns. This extensive program, announced in September 2025, represents a major investment in maternal-fetal medicine and neonatal care. The initiative aims to address critical gaps in our understanding of the complex factors contributing to these tragic events. Key areas of focus include identifying biomarkers for risk, developing novel interventions, and improving access to quality care for all expectant mothers. This builds upon previous NIH efforts in perinatal research and infant mortality reduction.

Core Research Areas & Funding Allocation

The NIH initiative is structured around several core research areas, each receiving ample funding. Here’s a breakdown:

* Biomarker Discovery: $75 million allocated to identifying and validating biomarkers that can predict risk of stillbirth and neonatal complications. This includes research into placental function, maternal immune responses, and fetal genetic factors. Fetal health monitoring will be a key component.

* Novel Therapeutic Interventions: $60 million dedicated to developing and testing new therapies to prevent and treat conditions leading to stillbirth and neonatal morbidity.This encompasses research into areas like preeclampsia, fetal growth restriction, and infection.

* Data Science & Predictive Modeling: $40 million invested in leveraging big data and artificial intelligence to create predictive models that can identify high-risk pregnancies and personalize care. Precision medicine plays a crucial role here.

* implementation Science & Health Equity: $25 million focused on ensuring that research findings are translated into effective clinical practise and that all women,regardless of socioeconomic status or geographic location,have access to high-quality maternal and neonatal care. addressing healthcare disparities is paramount.

Key Focus Areas: Specific Conditions Targeted

The initiative prioritizes research into several specific conditions known to significantly contribute to stillbirth and poor neonatal outcomes:

* Preeclampsia & Eclampsia: Research will focus on early detection,prevention,and improved management of these hypertensive disorders of pregnancy.

* Fetal Growth Restriction (FGR): Studies will investigate the underlying causes of FGR and explore interventions to promote optimal fetal growth.

* Placental Dysfunction: A major emphasis will be placed on understanding the role of placental abnormalities in stillbirth and neonatal complications. placental pathology will be a critical area of study.

* Infections During Pregnancy: Research will explore the impact of maternal infections on fetal development and neonatal health,including Group B Streptococcus (GBS) and congenital infections.

* Genetic and Genomic Factors: Investigating the role of inherited genetic predispositions and de novo genomic mutations in stillbirth and neonatal illness.

Benefits of the NIH Initiative

The potential benefits of this initiative are far-reaching:

* Reduced Stillbirth Rates: The primary goal is to significantly lower the number of stillbirths in the United States, currently around 22,000 per year.

* Improved Neonatal Health: Fewer babies will be born with serious health problems,leading to reduced rates of neonatal intensive care unit (NICU) admissions and long-term disabilities.

* Enhanced Maternal Wellbeing: Addressing risk factors during pregnancy can also improve the health and wellbeing of mothers.

* Economic Impact: Reducing the burden of stillbirth and neonatal illness will result in substantial cost savings for the healthcare system.

* Advancements in Medical Knowledge: The research generated by this initiative will expand our understanding of the complex processes involved in pregnancy and fetal development.

Practical Implications for Healthcare Providers

Healthcare professionals involved in prenatal and neonatal care can anticipate several key changes:

  1. New Screening Guidelines: Expect updated screening guidelines incorporating newly identified biomarkers for risk.
  2. Advanced Diagnostic Tools: Access to more sophisticated diagnostic tools for assessing fetal health and placental function.
  3. Personalized Treatment protocols: implementation of personalized treatment protocols based on individual risk profiles.
  4. Increased Collaboration: Enhanced collaboration between obstetricians, neonatologists, and other specialists.
  5. Telehealth Integration: Expanded use of telehealth to improve access to care, particularly in rural and underserved areas. Remote patient monitoring will become more prevalent.

Real-World Example: The Role of the Collaborative Pediatric critical Care Research Network (CPCCRN)

The NIH frequently enough leverages existing research networks like the CPCCRN to accelerate progress.The CPCCRN, a network of leading pediatric intensive care units, has been instrumental in conducting large-scale clinical trials and collecting valuable data on neonatal outcomes. This infrastructure will be crucial for evaluating the effectiveness of new interventions developed through the NIH initiative. Their work on neonatal sepsis and bronchopulmonary dysplasia provides a strong foundation for future research.

Resources for Expectant Parents & Healthcare Professionals

* NIH Website: https://www.nih.gov/ (Search for “stillbirth initiative” or “neon

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Adblock Detected

Please support us by disabling your AdBlocker extension from your browsers for our website.